US Stock MarketDetailed Quotes

Atara Biotherapeutics (ATRA)

Watchlist
  • 9.580
  • -0.010-0.10%
Close May 15 16:00 ET
  • 9.390
  • -0.190-1.98%
Post 19:54 ET
86.32MMarket Cap-7.85P/E (TTM)

Atara Biotherapeutics (ATRA) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
-39.60%8.36M
-80.04%8.48M
-80.04%8.48M
-79.59%13.71M
-36.75%22.32M
-70.07%13.84M
-17.84%42.5M
-17.84%42.5M
-34.39%67.19M
-77.03%35.29M
-Cash and cash equivalents
-39.60%8.36M
-66.11%8.48M
-66.11%8.48M
-87.64%5.74M
-46.02%16.9M
-60.55%13.84M
-3.14%25.03M
-3.14%25.03M
-28.30%46.45M
-31.77%31.31M
-Short-term investments
----
--0
--0
-61.56%7.97M
36.25%5.42M
--0
-32.52%17.47M
-32.52%17.47M
-44.88%20.74M
-96.31%3.98M
Receivables
--0
-15.45%1.25M
-15.45%1.25M
43.30%1.91M
--0
-75.23%8.88M
-95.65%1.48M
-95.65%1.48M
719.02%1.34M
377.71%2.42M
-Accounts receivable
--0
-15.45%1.25M
-15.45%1.25M
43.30%1.91M
--0
-75.23%8.88M
-95.65%1.48M
-95.65%1.48M
719.02%1.34M
377.71%2.42M
Inventory
----
--0
--0
--0
--0
--0
9.78%10.66M
9.78%10.66M
112.11%13.98M
138.51%18.75M
Restricted cash
----
--0
--0
--0
--0
0.00%146K
0.00%146K
0.00%146K
0.00%146K
0.00%146K
Other current assets
-11.74%3.81M
-75.51%2.48M
-75.51%2.48M
-69.51%2.81M
-57.78%2.45M
-46.87%4.32M
63.57%10.12M
63.57%10.12M
-1.95%9.21M
-42.93%5.8M
Total current assets
-55.22%12.17M
-81.18%12.21M
-81.18%12.21M
-79.93%18.43M
-60.31%24.77M
-74.46%27.18M
-36.30%64.89M
-36.30%64.89M
-22.61%91.86M
-63.78%62.41M
Non current assets
Net PPE
-78.34%6.93M
-82.64%7.14M
-82.64%7.14M
-77.15%10.85M
-78.15%11.2M
-41.76%32.01M
-30.09%41.1M
-30.09%41.1M
-25.56%47.49M
-24.10%51.27M
-Gross PPE
-79.43%6.93M
-87.42%7.35M
-87.42%7.35M
-82.82%11.26M
-83.14%11.58M
-52.98%33.71M
-21.77%58.41M
-21.77%58.41M
-16.81%65.54M
-15.97%68.67M
-Accumulated depreciation
----
98.77%-213K
98.77%-213K
97.76%-404K
97.85%-375K
89.86%-1.7M
-9.06%-17.31M
-9.06%-17.31M
-20.43%-18.05M
-22.75%-17.4M
Other non current assets
-68.71%890K
-71.45%886K
-71.45%886K
-73.76%881K
-74.31%927K
-26.47%2.84M
-35.94%3.1M
-35.94%3.1M
-46.62%3.36M
-45.11%3.61M
Total non current assets
-77.55%7.82M
-81.85%8.02M
-81.85%8.02M
-76.92%11.74M
-77.89%12.13M
-40.76%34.86M
-30.54%44.2M
-30.54%44.2M
-27.45%50.85M
-25.97%54.87M
Total assets
-67.77%20M
-81.45%20.24M
-81.45%20.24M
-78.86%30.17M
-68.54%36.9M
-62.46%62.04M
-34.08%109.1M
-34.08%109.1M
-24.41%142.71M
-52.41%117.28M
Liabilities
Current liabilities
Payables
-53.97%637K
-97.09%127K
-97.09%127K
-85.18%318K
-66.46%1.76M
-51.51%1.38M
18.54%4.37M
18.54%4.37M
-67.04%2.15M
26.95%5.25M
-accounts payable
-53.97%637K
-97.09%127K
-97.09%127K
-85.18%318K
-66.46%1.76M
-51.51%1.38M
18.54%4.37M
18.54%4.37M
-67.04%2.15M
26.95%5.25M
Current accrued expenses
-83.63%1.97M
-85.73%2.03M
-85.73%2.03M
-79.83%3.04M
-54.82%6.4M
-65.63%12.01M
-61.56%14.23M
-61.56%14.23M
-54.69%15.06M
-57.02%14.16M
Current debt and capital lease obligation
-92.71%1.01M
-92.61%1.03M
-92.61%1.03M
-86.68%1.95M
-83.98%2.24M
-0.83%13.92M
14.27%13.92M
14.27%13.92M
10.24%14.66M
8.07%14M
-Current capital lease obligation
-92.71%1.01M
-92.61%1.03M
-92.61%1.03M
-86.68%1.95M
-83.98%2.24M
-0.83%13.92M
14.27%13.92M
14.27%13.92M
10.24%14.66M
8.07%14M
Current deferred liabilities
-95.72%684K
-99.25%716K
-99.25%716K
-99.13%1.01M
-98.51%1.61M
-87.02%15.98M
22.17%95.09M
22.17%95.09M
902.02%116.34M
800.34%107.58M
Other current liabilities
--715K
2,452.36%9.75M
2,452.36%9.75M
--9.67M
----
----
--382K
--382K
----
----
Current liabilities
-88.21%5.65M
-88.91%14.92M
-88.91%14.92M
-88.42%18.06M
-90.18%14.56M
-73.49%47.89M
-5.38%134.57M
-5.38%134.57M
97.22%155.98M
98.88%148.27M
Non current liabilities
Long term debt and capital lease obligation
-66.02%9.08M
-68.75%9.35M
-68.75%9.35M
-57.42%15.01M
-60.14%15.43M
-36.71%26.71M
-34.53%29.91M
-34.53%29.91M
-27.35%35.24M
-25.22%38.7M
-Long term capital lease obligation
-66.02%9.08M
-68.75%9.35M
-68.75%9.35M
-57.42%15.01M
-60.14%15.43M
-36.71%26.71M
-34.53%29.91M
-34.53%29.91M
-27.35%35.24M
-25.22%38.7M
Non current deferred liabilities
----
----
----
----
--0
--0
--0
--0
-99.36%470K
-99.25%567K
Other non current liabilities
0.18%42.59M
-17.72%34.47M
-17.72%34.47M
-18.80%33.74M
3.30%41.95M
6.34%42.51M
6.72%41.89M
6.72%41.89M
757.12%41.55M
708.58%40.62M
Total non current liabilities
-25.36%51.66M
-38.98%43.82M
-38.98%43.82M
-36.91%48.74M
-28.17%57.38M
-16.49%69.22M
-41.39%71.81M
-41.39%71.81M
-51.87%77.27M
-51.42%79.89M
Total liabilities
-51.06%57.31M
-71.54%58.74M
-71.54%58.74M
-71.36%66.8M
-68.47%71.94M
-55.57%117.11M
-22.04%206.38M
-22.04%206.38M
-2.66%233.25M
-4.53%228.15M
Shareholders'equity
Share capital
0.00%1K
0.00%1K
0.00%1K
0.00%1K
--1K
-91.67%1K
--1K
--1K
-90.00%1K
--0
-common stock
0.00%1K
0.00%1K
0.00%1K
0.00%1K
--1K
-91.67%1K
--1K
--1K
-90.00%1K
--0
Retained earnings
-0.47%-2.03B
1.59%-2.02B
1.59%-2.02B
1.15%-2.02B
0.29%-2.01B
-0.78%-2.02B
-4.34%-2.05B
-4.34%-2.05B
-6.98%-2.04B
-9.85%-2.02B
Paid-in capital
1.39%1.99B
1.33%1.98B
1.33%1.98B
1.56%1.98B
3.67%1.98B
3.09%1.96B
4.66%1.96B
4.66%1.96B
5.00%1.95B
3.35%1.91B
Gains losses not affecting retained earnings
--0
-87.50%1K
-87.50%1K
-90.91%2K
--0
--0
103.92%8K
103.92%8K
103.85%22K
98.50%-14K
Total stockholders'equity
32.25%-37.31M
60.42%-38.5M
60.42%-38.5M
59.54%-36.63M
68.39%-35.04M
43.98%-55.07M
1.96%-97.28M
1.96%-97.28M
-78.09%-90.54M
-1,587.36%-110.87M
Total equity
32.25%-37.31M
60.42%-38.5M
60.42%-38.5M
59.54%-36.63M
68.39%-35.04M
43.98%-55.07M
1.96%-97.28M
1.96%-97.28M
-78.09%-90.54M
-1,587.36%-110.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments -39.60%8.36M-80.04%8.48M-80.04%8.48M-79.59%13.71M-36.75%22.32M-70.07%13.84M-17.84%42.5M-17.84%42.5M-34.39%67.19M-77.03%35.29M
-Cash and cash equivalents -39.60%8.36M-66.11%8.48M-66.11%8.48M-87.64%5.74M-46.02%16.9M-60.55%13.84M-3.14%25.03M-3.14%25.03M-28.30%46.45M-31.77%31.31M
-Short-term investments ------0--0-61.56%7.97M36.25%5.42M--0-32.52%17.47M-32.52%17.47M-44.88%20.74M-96.31%3.98M
Receivables --0-15.45%1.25M-15.45%1.25M43.30%1.91M--0-75.23%8.88M-95.65%1.48M-95.65%1.48M719.02%1.34M377.71%2.42M
-Accounts receivable --0-15.45%1.25M-15.45%1.25M43.30%1.91M--0-75.23%8.88M-95.65%1.48M-95.65%1.48M719.02%1.34M377.71%2.42M
Inventory ------0--0--0--0--09.78%10.66M9.78%10.66M112.11%13.98M138.51%18.75M
Restricted cash ------0--0--0--00.00%146K0.00%146K0.00%146K0.00%146K0.00%146K
Other current assets -11.74%3.81M-75.51%2.48M-75.51%2.48M-69.51%2.81M-57.78%2.45M-46.87%4.32M63.57%10.12M63.57%10.12M-1.95%9.21M-42.93%5.8M
Total current assets -55.22%12.17M-81.18%12.21M-81.18%12.21M-79.93%18.43M-60.31%24.77M-74.46%27.18M-36.30%64.89M-36.30%64.89M-22.61%91.86M-63.78%62.41M
Non current assets
Net PPE -78.34%6.93M-82.64%7.14M-82.64%7.14M-77.15%10.85M-78.15%11.2M-41.76%32.01M-30.09%41.1M-30.09%41.1M-25.56%47.49M-24.10%51.27M
-Gross PPE -79.43%6.93M-87.42%7.35M-87.42%7.35M-82.82%11.26M-83.14%11.58M-52.98%33.71M-21.77%58.41M-21.77%58.41M-16.81%65.54M-15.97%68.67M
-Accumulated depreciation ----98.77%-213K98.77%-213K97.76%-404K97.85%-375K89.86%-1.7M-9.06%-17.31M-9.06%-17.31M-20.43%-18.05M-22.75%-17.4M
Other non current assets -68.71%890K-71.45%886K-71.45%886K-73.76%881K-74.31%927K-26.47%2.84M-35.94%3.1M-35.94%3.1M-46.62%3.36M-45.11%3.61M
Total non current assets -77.55%7.82M-81.85%8.02M-81.85%8.02M-76.92%11.74M-77.89%12.13M-40.76%34.86M-30.54%44.2M-30.54%44.2M-27.45%50.85M-25.97%54.87M
Total assets -67.77%20M-81.45%20.24M-81.45%20.24M-78.86%30.17M-68.54%36.9M-62.46%62.04M-34.08%109.1M-34.08%109.1M-24.41%142.71M-52.41%117.28M
Liabilities
Current liabilities
Payables -53.97%637K-97.09%127K-97.09%127K-85.18%318K-66.46%1.76M-51.51%1.38M18.54%4.37M18.54%4.37M-67.04%2.15M26.95%5.25M
-accounts payable -53.97%637K-97.09%127K-97.09%127K-85.18%318K-66.46%1.76M-51.51%1.38M18.54%4.37M18.54%4.37M-67.04%2.15M26.95%5.25M
Current accrued expenses -83.63%1.97M-85.73%2.03M-85.73%2.03M-79.83%3.04M-54.82%6.4M-65.63%12.01M-61.56%14.23M-61.56%14.23M-54.69%15.06M-57.02%14.16M
Current debt and capital lease obligation -92.71%1.01M-92.61%1.03M-92.61%1.03M-86.68%1.95M-83.98%2.24M-0.83%13.92M14.27%13.92M14.27%13.92M10.24%14.66M8.07%14M
-Current capital lease obligation -92.71%1.01M-92.61%1.03M-92.61%1.03M-86.68%1.95M-83.98%2.24M-0.83%13.92M14.27%13.92M14.27%13.92M10.24%14.66M8.07%14M
Current deferred liabilities -95.72%684K-99.25%716K-99.25%716K-99.13%1.01M-98.51%1.61M-87.02%15.98M22.17%95.09M22.17%95.09M902.02%116.34M800.34%107.58M
Other current liabilities --715K2,452.36%9.75M2,452.36%9.75M--9.67M----------382K--382K--------
Current liabilities -88.21%5.65M-88.91%14.92M-88.91%14.92M-88.42%18.06M-90.18%14.56M-73.49%47.89M-5.38%134.57M-5.38%134.57M97.22%155.98M98.88%148.27M
Non current liabilities
Long term debt and capital lease obligation -66.02%9.08M-68.75%9.35M-68.75%9.35M-57.42%15.01M-60.14%15.43M-36.71%26.71M-34.53%29.91M-34.53%29.91M-27.35%35.24M-25.22%38.7M
-Long term capital lease obligation -66.02%9.08M-68.75%9.35M-68.75%9.35M-57.42%15.01M-60.14%15.43M-36.71%26.71M-34.53%29.91M-34.53%29.91M-27.35%35.24M-25.22%38.7M
Non current deferred liabilities ------------------0--0--0--0-99.36%470K-99.25%567K
Other non current liabilities 0.18%42.59M-17.72%34.47M-17.72%34.47M-18.80%33.74M3.30%41.95M6.34%42.51M6.72%41.89M6.72%41.89M757.12%41.55M708.58%40.62M
Total non current liabilities -25.36%51.66M-38.98%43.82M-38.98%43.82M-36.91%48.74M-28.17%57.38M-16.49%69.22M-41.39%71.81M-41.39%71.81M-51.87%77.27M-51.42%79.89M
Total liabilities -51.06%57.31M-71.54%58.74M-71.54%58.74M-71.36%66.8M-68.47%71.94M-55.57%117.11M-22.04%206.38M-22.04%206.38M-2.66%233.25M-4.53%228.15M
Shareholders'equity
Share capital 0.00%1K0.00%1K0.00%1K0.00%1K--1K-91.67%1K--1K--1K-90.00%1K--0
-common stock 0.00%1K0.00%1K0.00%1K0.00%1K--1K-91.67%1K--1K--1K-90.00%1K--0
Retained earnings -0.47%-2.03B1.59%-2.02B1.59%-2.02B1.15%-2.02B0.29%-2.01B-0.78%-2.02B-4.34%-2.05B-4.34%-2.05B-6.98%-2.04B-9.85%-2.02B
Paid-in capital 1.39%1.99B1.33%1.98B1.33%1.98B1.56%1.98B3.67%1.98B3.09%1.96B4.66%1.96B4.66%1.96B5.00%1.95B3.35%1.91B
Gains losses not affecting retained earnings --0-87.50%1K-87.50%1K-90.91%2K--0--0103.92%8K103.92%8K103.85%22K98.50%-14K
Total stockholders'equity 32.25%-37.31M60.42%-38.5M60.42%-38.5M59.54%-36.63M68.39%-35.04M43.98%-55.07M1.96%-97.28M1.96%-97.28M-78.09%-90.54M-1,587.36%-110.87M
Total equity 32.25%-37.31M60.42%-38.5M60.42%-38.5M59.54%-36.63M68.39%-35.04M43.98%-55.07M1.96%-97.28M1.96%-97.28M-78.09%-90.54M-1,587.36%-110.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More